Insufficient scRNA-seq data for expression of CNTD1 at single-cell level.
Insufficient scRNA-seq data for expression of CNTD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 216.83 | 245 / 245 | 91% | 3.31 | 459 / 502 |
breast | 100% | 179.63 | 459 / 459 | 71% | 2.57 | 792 / 1118 |
brain | 98% | 84.95 | 2599 / 2642 | 69% | 1.20 | 486 / 705 |
intestine | 100% | 174.98 | 966 / 966 | 67% | 1.54 | 352 / 527 |
stomach | 100% | 302.34 | 359 / 359 | 60% | 1.39 | 171 / 286 |
esophagus | 100% | 124.73 | 1444 / 1445 | 53% | 1.01 | 97 / 183 |
bladder | 100% | 99.95 | 21 / 21 | 50% | 1.15 | 251 / 504 |
lung | 100% | 158.56 | 577 / 578 | 47% | 1.01 | 541 / 1155 |
uterus | 100% | 111.48 | 170 / 170 | 44% | 1.48 | 201 / 459 |
pancreas | 100% | 110.18 | 328 / 328 | 40% | 0.77 | 72 / 178 |
skin | 100% | 116.77 | 1805 / 1809 | 35% | 0.57 | 163 / 472 |
ovary | 100% | 117.13 | 180 / 180 | 32% | 0.57 | 137 / 430 |
kidney | 100% | 175.27 | 89 / 89 | 23% | 0.38 | 204 / 901 |
thymus | 100% | 151.22 | 653 / 653 | 10% | 0.12 | 59 / 605 |
liver | 100% | 78.23 | 225 / 226 | 10% | 0.18 | 40 / 406 |
adrenal gland | 100% | 106.06 | 258 / 258 | 3% | 0.05 | 8 / 230 |
adipose | 100% | 126.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 256.87 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 93.06 | 878 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 94% | 69.35 | 1260 / 1335 | 0% | 0 | 0 / 0 |
heart | 92% | 52.21 | 794 / 861 | 0% | 0 | 0 / 0 |
muscle | 53% | 22.48 | 428 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 51% | 2.52 | 23 / 45 |
eye | 0% | 0 | 0 / 0 | 16% | 0.22 | 13 / 80 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.18 | 4 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007131 | Biological process | reciprocal meiotic recombination |
GO_0007283 | Biological process | spermatogenesis |
GO_0051445 | Biological process | regulation of meiotic cell cycle |
GO_0005694 | Cellular component | chromosome |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
Gene name | CNTD1 |
Protein name | Cyclin N-terminal domain containing 1 Cyclin N-terminal domain-containing protein 1 Cyclin N-terminal domain containing 1 (Cyclin N-terminal domain containing, isoform CRA_b) (cDNA FLJ50910) |
Synonyms | hCG_16966 CNTD |
Description | FUNCTION: Plays a role in the different steps of crossover formation during meiotic recombination. Participates in the crossover differentiation step of crossover-specific recombination intermediates through its interaction with PRR19. In addition, stimulates crossover formation through the interactions with RFC3 and RFC4 and simultaneously regulates cell-cycle progression through interactions with CDC34 and subsequent ubiquitination of WEE1. May also participates in an active deselection process that destabilizes or removes excess pre-CO intermediates. . |
Accessions | K7ERX8 ENST00000585355.5 ENST00000588527.5 K7ELB6 K7EQE2 ENST00000592166.5 Q8N815 B4DXR6 ENST00000586652.1 ENST00000588408.6 [Q8N815-1] |